Company Profile

BioTools Inc
Profile last edited on: 3/27/14      CAGE: 3EX07      UEI:

Business Identifier: biopharmaceuticals and chiral-organic drugs
Year Founded
2000
First Award
2005
Latest Award
2010
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

17546 Bee Line Highway (SR 710)
Jupiter, FL 33458
   (561) 625-0133
   info@btools.com
   www.btools.com
Location: Multiple
Congr. District: 18
County: Palm Beach

Public Profile

BioTools provides instrumentation and services to pharmaceutical and biotechnology companies in several niche markets. They concentrate in the areas of biopharmaceuticals and chiral-organic drugs. Their unique products are used for molecular structure characterization from active ingredient to formulated finished products. BioTools was the first company to commercialize two ground-breaking techniques in vibrational spectroscopy - Vibrational Circular Dichroism (VCD) and Raman Optical Activity (ROA). VCD is the most sought after technique for determination of absolute configuration of chiral molecules, including natural products and chiral API's. ROA is mostly used for structure characterization of glyco-proteins, proteins, viruses and nucleic acids.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NSF $601,690
Project Title: Vibrational CD Microscopy for Characterizing Supramolecular Bio-Chirality
2007 2 AF $850,000
Project Title: Surface-Enhanced Detection of Molecular and Biomolecular Species

Key People / Management

  Rina Dukor -- President

  Laurence A Nafie

Company News

There are no news available.